R&D Systems™ Recombinant Human Cadherin-9 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 9984CA050
DescriptionThe Recombinant Human Cadherin-9 Fc Chimera Protein is derived from HEK293. The Recombinant Human Cadherin-9 Fc Chimera Protein has been validated for the following applications: Bioactivity.
|12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.|
|Reconstitute at 250 μg/mL in PBS.|
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.|
|Human embryonic kidney cell,HEK293-derived human Cadherin-9 protein, (N-terminus) Human Cadherin-9 (Gly54-Ala615) Accession &Num; Q9ULB4 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|Lyophilized from a 0.2 μm filtered solution in PBS.|